A phase IB clinical trial with Dekavil (F8-IL10), an immunoregulatory 'armed antibody' for the treatment of rheumatoid arthritis, used in combination wiIh methotrexate.

Subjects

Subjects :

Antibodies
Antirheumatic Agents administration & dosage
Arthritis, Rheumatoid immunology
Arthritis, Rheumatoid physiopathology
Dose-Response Relationship, Drug
Drug Delivery Systems
Drug Monitoring
Drug Therapy, Combination methods
Humans
Immunologic Factors immunology
Immunologic Factors pharmacology
Injections, Subcutaneous
Maximum Tolerated Dose
Pilot Projects
Arthritis, Rheumatoid drug therapy
Fibronectins immunology
Fibronectins pharmacology
Interleukin-10 immunology
Interleukin-10 pharmacology
Methotrexate administration & dosage

Details

Language :

English

ISSN :

1565-1088

Volume :

16

Issue :

10

Database :

MEDLINE

Journal :

The Israel Medical Association journal : IMAJ

Publication Type :

Academic Journal

Accession number :

25438467